Upload
PPT-Figure 1 Figure 1. Epidemiologic context for emergence of vaccine-derived polioviruses

PPT-Figure 1 Figure 1. Epidemiologic context for emergence of vaccine-derived polioviruses

Author : davis | Published Date : 2024-09-06

FernandezGarcia M Majumdar M Kebe O Fall AD Kone M Kande M et al Emergence of VaccineDerived Polioviruses during Ebola Virus Disease Outbreak Guinea 20142015 Emerg

vaccine 2015 case ebola vaccine ebola case contacts circles paralysis derived emergence onset opv polio patients laboratory

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure 1 Figure 1. Epidemiologic context..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure 1 Figure 1. Epidemiologic context for emergence of vaccine-derived polioviruses: Transcript

Download Document

Here is the link to download the presentation.
"Figure 1 Figure 1. Epidemiologic context for emergence of vaccine-derived polioviruses"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents

Ebola: Progress with Vaccines

Ebola: Progress with Vaccines
Fact Sheet

Fact Sheet
Figure 1 Figure 1. A) Standard curves of Ebola virus spiked into 3 matrices: semen, blood,

Figure 1 Figure 1. A) Standard curves of Ebola virus spiked into 3 matrices: semen, blood,
Figure 3 Figure 3. . Age distribution of children with measles reported in Malawi, 2010.

Figure 3 Figure 3. . Age distribution of children with measles reported in Malawi, 2010.
Figure 2 Figure 2. HLA haplotypes identified among the control group, Ebola survivors,

Figure 2 Figure 2. HLA haplotypes identified among the control group, Ebola survivors,
Figure 1 Figure 1. Epidemiologic curve of Yersinia enterocolitica outbreak in

Figure 1 Figure 1. Epidemiologic curve of Yersinia enterocolitica outbreak in
Figure 1 Figure 1. Changes to routine childhood pertussis immunization programs

Figure 1 Figure 1. Changes to routine childhood pertussis immunization programs
Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata

Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata
Figure 1 Figure 1. Landsat Thematic Mapper (TM) satellite data for a 6x6-km area

Figure 1 Figure 1. Landsat Thematic Mapper (TM) satellite data for a 6x6-km area
Figure 2 Figure 2. Comparison of the most common post-Ebola syndrome symptoms with admission

Figure 2 Figure 2. Comparison of the most common post-Ebola syndrome symptoms with admission
Figure Figure. Schematic illustration of the epidemiologic relationships between

Figure Figure. Schematic illustration of the epidemiologic relationships between
Figure 1 Figure 1. Slit lamp examination of the left eye of a physician from the United

Figure 1 Figure 1. Slit lamp examination of the left eye of a physician from the United
Figure Figure. Ebola virus inactivation results as tested in BALB/c mouse model. A) Survival

Figure Figure. Ebola virus inactivation results as tested in BALB/c mouse model. A) Survival